@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:show . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:56:02.754101"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "encouraging resultswhile vaccines are currently being evaluated in phase III trials" . rdf:OBJECT-POSITION rdfs:label "66"^^xsd:integer . rdf:PREDICATE rdfs:label "shown" . rdf:PREDICATE-POSITION rdfs:label "[75]" . rdf:SUBJECT rdfs:label "dexamethasone and remdesivir" . rdf:SUBJECT-POSITION rdfs:label "41"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "5w69zahg" . rdfs:SENTENCE rdfs:label "For those of COVID-19 related pneumonia, dexamethasone and remdesivir have shown encouraging results, while vaccines are currently being evaluated in phase III trials." . rdfs:TRIPLE-UID ns3:5w69zahg-TRIPLE-ABSTRACT-1 "5w69zahg-TRIPLE-ABSTRACT-1" . rdfs:label "dexamethasone" . rdfs:label "phase" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "VigTc5T1AciXogbmRbVwfpUOFNG9j5wXV+KwhqUCeTKwPy4NukKhQKaot+niC/jKJRFHbZuL6tdLLE9Tme5STL4gCvIQYNsSJfviTie+vI/GgsZwGzatfn521ynEGgcDSEhfq0022d7MfL+CnsSxSOoMP/hQCLoP7ZXmaza1J74="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:56:02.754101"^^xsd:dateTime; prov:wasAttributedTo . }